Regenerative MedicineJuly 21, 2026
PRP vs. Donor-Derived "Stem Cell" Products for Joint Pain
Umbilical cord, Wharton’s jelly, amniotic, and exosome injections are widely marketed as "stem cell therapy" for joint pain. The FDA does not approve these products for joints — and in 2024 sent letters to companies selling them. Here is what that means for you.
Latest ArticleUmbilical cord, Wharton’s jelly, amniotic, and exosome injections are widely marketed as "stem cell therapy" for joint pain. The FDA does not approve these products for joints — and in 2024 sent letters to companies selling them. Here is what that means for you.